Search clinical trials for: juvenile myelomonocytic leukemia

Total 9564 results

Ann & Robert H Lurie Children's Hospital of Chicago

Completed

WT1 for the Detection of Minimal Residual Disease

Leukemia | Cancer

United States
Groupe d'etude et de travail sur les leucemies...
University Hospital, Lille

Completed

A Randomized Trial Assessing the Roles of AraC in Newly Diagnosed APL Promyelocytic Leukemia (APL)

Leukemia, Promyelocytic, Acute
MedImmune LLC
Cambridge Antibody Technology

Suspended

BL22 Immunotoxin In Treating Young Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma

Lymphoma | Leukemia

United States
Dana-Farber Cancer Institute
Boston Children's Hospital

Terminated

Treatment of Childhood Acute Lymphoblastic Leukemia

Acute Lymphoblastic Leukemia

United States, Puerto Rico, Canada
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Combination of Levonorgestrel and Ethinyl Estradiol in Pre-Menstrual Dysphoric Disorder

Menstruation Disturbances | Premenstrual Syndrome

Poland, United Kingdom, Germany, Argentina, Mexico, Romania, Netherlands, Finland, Chile, Brazil, Sweden, Denmark
Cell Genesys

Completed

Vaccination in the Peripheral Stem Cell Transplant Setting for Acute Myelogenous Leukemia

Acute Myelogenous Leukemia

United States
Callisto Pharmaceuticals

Unknown

Study of Liposomal Annamycin in Patients With Refractory or Relapsed Acute Lymphocytic Leukemia

Acute Lymphocytic Leukemia

United States
University of Zurich
AstraZeneca

Completed

Study to Assess Management Strategies for the Use of Esomeprazole (Nexium) in Helicobacter Pylori Infected Patients

Gastroesophageal Reflux Disease (GERD)

Switzerland
Norgine

Completed

MOVIPREP® Versus PICOLAX® Pilot Study

Colonoscopy

United Kingdom
Astex Pharmaceuticals, Inc.
Eisai Inc.

Completed

Phase II Trial of Decitabine in Patients With Chronic Myelogenous Leukemia Accelerated Phase Who Are Refractory to Imatinib Mesylate (Gleevec)

Chronic Myelogenous Leukemia

United States, Canada
University of Aarhus
The Danish Multiple Sclerosis Society

Completed

Fatigue in Multiple Sclerosis: Evaluated With 3 MRI and Transcranial Magnetic Stimulation

Multiple Sclerosis | Fatigue

Denmark
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating the Tolerance and Safety of Enbrel (Etanercept) in Adults and Children

Rheumatoid Arthritis
Sheba Medical Center

Unknown

Adipokines as Predictors of the Metabolic Syndrome in ALL Survivors

Leukemia | Metabolic Syndrome X
Handok Inc.

Completed

Male Sexual Health Questionnaire (MSHQ) - Sexual Function Study

Prostatic Hyperplasia

Korea, Republic of
Centre National de Greffe de Moelle Osseuse

Unknown

Trial of Filgrastim Versus Placebo Following Allogeneic Bone Marrow Transplantation

Graft vs Host Disease

Tunisia
Sheba Medical Center

Completed

Pulmonary Function at Presentation and Follow-up in Hemato-Oncology 3-7 Years Old Children

Acute Lymphoblastic Leukemia | Hodgkin's Disease | Acute Myeloblastic Leukemia | Solid Tumors, | Non-Malignant

Israel
French Innovative Leukemia Organisation

Completed

Treatment of Disseminated High Grade Lymphoma

Lymphoma

France
French Innovative Leukemia Organisation

Completed

Treatment of Localized Low Grade Lymphomas

Lymphoma, Low-Grade

France
French Innovative Leukemia Organisation

Completed

Phase III Study Treatment of CLL B and C

Leukemia, Lymphocytic, Chronic
German AML Cooperative Group

Unknown

Treatment Protocol for Relapsed Acute Promyelocytic Leukemia (APL) With Arsenic

Relapsed Acute Promyelocytic Leukemia | Refractory Acute Promyelocytic Leukemia

Germany
Johann Wolfgang Goethe University Hospital

Unknown

Study Comparing Imatinib With Chemotherapy as Induction in Elderly Patients With Philadelphia Positive Acute Lymphoblastic Leukemia (ALL)

Philadelphia Positive Acute Lymphoblastic Leukemia | Lymphoid Blastic Phase of Chronic Myeloid Leukemia

Germany
Sheba Medical Center

Unknown

Imatinib Versus Imatinib and Peg-Interferon in Patients With Ph+ CML and Complete Cytogenetic Response After Imatinib Therapy

Leukemia, Myeloid, Philadelphia-Positive

Israel
Gruppo Italiano Malattie EMatologiche dell'Adulto

Completed

Adult ALL Treatment at Diagnosis (LAL2000)

Leukemia, Lymphocytic, Acute

Italy
Cooperative Study Group A for Hematology

Unknown

Fludarabine and Cytarabine as Continuous Infusion Plus G-CSF Priming for Elderly Patients With Resistant AML

Acute Myeloid Leukemia

Korea, Republic of
Weintraub, Michael I., MD, FACP, FAAN

Completed

Autonomic Nervous System Dysfunction and Peripheral Neuropathy in a Cohort of Asymptomatic Juvenile Diabetic Patients (Type I): A Case-Controlled Study

Peripheral Neuropathy | Autonomic Neuropathy

United States
Daiichi Sankyo, Inc.

Completed

Study of CS-1008 in Patients With Advanced Solid Malignancies and Lymphomas (Without Leukemic Component)

Lymphoma | Malignancies

United States
National Taiwan University Hospital

Unknown

Functional Pharmacogenomics of Childhood Acute Lymphoblastic Leukemia in Taiwan

Leukemia, Lymphocytic, Acute

Taiwan
Groupe Hospitalier Pitie-Salpetriere
University Hospital, Tours

Unknown

Clinical, Molecular and Metabolic Characteristics of Parkinson's Disease (PD) Patients With Parkin Mutation

Parkinson's Disease

France
Gilead Sciences

Terminated

ProphyALL - Study on the Safety of Liposomal Amphotericin B to Prevent Antifungal Infections in Elderly Patients With Acute Lymphoblastic Leukemia

Fungal Infection

Germany
Christian Medical College, Vellore, India
Ministry of Science and Technology, India

Unknown

Single Agent Arsenic Trioxide in the Treatment of Newly Diagnosed Acute Promyelocytic Leukemia (IAPLSG04)

Acute Promyelocytic Leukemia

India
Cambridge Antibody Technology

Unknown

Safety Study of CAT-8015 Immunoxin in Patients With NHL With Advance Disease (NHL)

Leukemia | Non-Hodgkin's Lymphoma | NHL

United States, Poland
University of Bologna
Novartis

Completed

Imatinib Standard Dose (400 mg/Day) Versus Imatinib High Dose (800 mg/Day) (CML022)

Chronic Myeloid Leukemia

Italy
University of Bologna

Completed

Protein-Tyrosine Kinase Inhibitor (STI571) for Treatment of Patients With Ph+ Chronic Myeloid Leukemia in Accelerated and Blastic Phase (CML003)

Chronic Myeloid Leukemia

Italy
University of Bologna
Novartis; Schering-Plough

Terminated

Study of the Combination of a Tyrosine Kinase Inhibitor (STI571) and a Pegylated Human Recombinant Interferon alfa2b (PEGINTRON)

Chronic Myeloid Leukemia
University of Bologna
Novartis

Completed

Protein-Tyrosine Kinase Inhibitor (STI571) for Treatment of Patients With Ph+ Chronic Myeloid Leukemia

Chronic Myeloid Leukemia
University of Bologna

Completed

Exploratory Study of IMATINIB High Dose in Intermediate Risk Chronic Myeloid Leukemia in Chronic Phase

Myeloid Leukemia, Chronic, Chronic-Phase

Italy
Sundsvall Hospital

Completed

Adjuvant I.V. Iron Therapy During Erythropoetin Treatment of Anemic Patients With Lymphoproliferative Disorders.

Multiple Myeloma | Anemia | Chronic Lymphocytic Leukemia | Non Hodgkin Lymphoma

Sweden
Karolinska University Hospital
Schering Nordiska AB

Completed

Study to Evaluate the Safety of Subcutaneous Alemtuzumab in Patients With B-Cell Chronic Lymphocytic Leukemia

B-CLL

Sweden
Georgetown University

Completed

Urban Environmental Exposures and Childhood Cancer

Acute Lymphoblastic Leukemia | Brain Cancer

United States
Technische Universität Dresden

Completed

AML96 - Risk-Adapted and Randomized Postremission-Therapy for Adult Acute Myeloid Leukemia Patients

Leukemia, Nonlymphoblastic, Acute

Germany
MedImmune LLC

Terminated

Study to Evaluate MEDI-507 in Patients With CD2-Positive Lymphoma/Leukemia

Lymphoma | Leukemia | Cancer

United States
French Innovative Leukemia Organisation

Completed

Study of Treatment High Risk and/or Low Risk Acute Lymphoblastic leukémia(ALL) Adults Stage III

Leukemia, Lymphocytic, Acute

France
French Innovative Leukemia Organisation

Completed

Lomustine and Intermediate Dose Cytarabine in Older Patients With AML

Acute Myeloid Leukemia

France
Celgene Corporation

Terminated

Study to Determine the Optimal Biologic Dose of CC-401 in Subjects With High-Risk Myeloid Leukemia

Myeloid Leukemia

United States
Pamela Youde Nethersole Eastern Hospital

Unknown

Compare Efficacy of Gastric Acid Suppression by Oral and Intravenous Administration of Esomeprazole in Patients With Peptic Ulcer (NPH)

Peptic Ulcer

China
Novacea

Unknown

Study of AQ4N in Patients With Non Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, or Small Lymphocytic Leukemia

Non-Hodgkin's Lymphoma | Chronic Lymphocytic Leukemia | Small Lymphocytic Leukemia

United States
BeerYaakov Mental Health Center
Lundbeck Israel

Completed

The Efficacy of Escitalopram for Negative Symptoms in Schizophrenia

Schizophrenia

Israel
Hospices Civils de Lyon

Unknown

Treatment of Philadelphia-Positive Acute Lymphocytic Leukemia (Ph+ ALL) in the Elderly With Imatinib Mesylate (STI571) and Chemotherapy.

Acute Lymphocytic Leukemia

France
Hospices Civils de Lyon

Unknown

AFR10 - Combination Therapy of Imatinib Mesylate (IM) + Alpha-2A Interferon for Chronic Phase CML Patients Resistant or Refractory to IM Used as Single Therapy for at Least One Year

Chronic Myeloid Leukemia

France
Massachusetts General Hospital
Dana-Farber Cancer Institute; Beth Israel Deaconess Medical Center

Completed

Safety Study of Parathyroid Hormone in Patients Needing Additional Stem Cell Mobilization.

Lymphoma | Multiple Myeloma | Acute Myelogenous Leukemia

United States

Search clinical trials for: juvenile myelomonocytic leukemia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Slovakia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations